Funding Agency. A body providing resources to one or more of the Collaborating Institutions for the purpose of participation in the Experiment. A Collaborating Institution may itself be a Funding Agency.
Funding Agency. An agency of a Federal, State, Political subdivision, or Local Government which furnishes funds for the CONTRACTOR's compensation under this Agreement and which may have established regulations and requirements binding upon the CONTRACTING AGENCY and the CONTRACTOR.
Funding Agency. Netherlands Organisation for Health Research and Development, also referred to as ‘ZonMw’; - Grant Letter: the ZonMw letter that contains the Decision5 with respect to the award of the Grant6 for this Project; - In Cash Contribution: the in cash contribution of a Party to this Project according to the Project Budget as attached to this agreement in Schedule [ • ];
Funding Agency. The National Institutes of Health
Funding Agency. Requirements To the extent that this Agreement may be funded by fiscal assistance from another entity, Contractor shall comply with all applicable rules and regulations to which City is bound by the terms of such fiscal assistance program.
Funding Agency. Florida Department of Health in Sarasota County.
Funding Agency. American Heart Association American Heart Association (AHA) offers research funding programs to eligible investigators and institutions across the U.S. The AHA generally has two funding cycles per year and research awards are limited to non-profit institutions, including medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and others that can demonstrate the ability to conduct the proposed research. AHA continues to offer a variety of grant opportunities for scientists and researchers from many different fields of study to accomplish their goals to reverse and prevent cardiovascular diseases and stroke. Other funding agencies that sponsor these types of grants include the Centre of Disease Control (CDC) and National Institute of Health (NIH) which have extensive funding opportunities to combat and prevent chronic disease especially cardiovascular disease. The AHA was chosen specifically because of the direct correlation between hypertension and cardiovascular disease rates (Ramachandran X. Xxxxx, 2001). The grant covers research for the prevention of cardiovascular disease due to any cause and offers an opportunity for early investigators with supportive mentoring relationships to conduct introductory pilot studies that will guide future strategies for reducing cardiovascular disease and stroke. This pilot study will provide a basis for further investigation into the fact that by modifying dietary intake in pre-hypertensive patients, it can have a profound effect on the development of hypertension that may require medication in the future. Grant Announcement The grant announcement includes all clinical and population research broadly related to cardiovascular disease and stroke. The award amount is $154,000 divided into two year grants of $77,000 and is limited to Healthcare professional with a masters or post- baccalaureate doctoral degree with the inclusion of a sponsor for the proposal. The work is to be done at an accredited institution within the United States and research awards are limited to non-profit institutions, including: medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and other institutions that can demonstrate the ability to conduct the proposed research. The complete grant announcemen...
Funding Agency. A description of the products or services (including construction) being provided under the subcontract, including the overall purpose and expected outcomes or results of the subcontract.
Funding Agency. Sponsor’s code number (if external):
Funding Agency. The Principal Investigator shall furnish written reports on the progress of the work on dates mutually agreed upon and a final report on the entire Project within ninety (90) days after termination of this Agreement. Pursuant to 21 C.F.R. § 312.33, the Investigator must submit a yearly report to the Food and Drug Administration (FDA). Specifically, 21CFR §312.33, which includes, but not limited to the following mandates: “[a] sponsor shall within 60 days of the anniversary date that the IND went into effect, submit a brief report of the progress of the investigation that includes: (a) Individual study information. A brief summary of the status of each study in progress and each study completed during the previous year. “
